NEO-STIM

Welcome to the Brand page for “NEO-STIM”, which is offered here for Issue new certificate to: biontech us inc. (delaware corporation) 40 erie street, suite 110, cambridge ma 02139.;medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals;conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials;.

Its status is currently believed to be active. Its class is unavailable. “NEO-STIM” is believed to be currently owned by “BioNTech US Inc.”

Owner:
BIONTECH US INC.
Owner Details
Description:
Issue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.;Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals;Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials;
Categories: ISSUE NEW CERTIFICATE BIONTECH